Cart
sales@molnova.com
Home - Products - Others - Other Targets - PTEROIC ACID

PTEROIC ACID

CAS No. 119-24-4

PTEROIC ACID( —— )

Catalog No. M23003 CAS No. 119-24-4

Pteroic acid is part of the structure of folic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    PTEROIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    Pteroic acid is part of the structure of folic acid.
  • Description
    Pteroic acid is part of the structure of folic acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119-24-4
  • Formula Weight
    312.28
  • Molecular Formula
    C14H12N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=CC=C1C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ke C Y , Mathias C J , Green M A . Targeting the Tumor-Associated Folate Receptor with an 111 InDTPA Conjugate of Pteroic Acid[J]. Journal of the American Chemical Society, 2005, 127(20):7421-7426.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • 1,2-Dimyristoyl-sn-g...

    1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) is a synthetic phospholipid used in liposomes which is used for the study of lipid monolayers and bilayers.

  • Cergutuzumab amunale...

    Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with immunostimulatory and anti-tumor activities for the study of solid cancers.

  • Pivagabine

    Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.

Sign In Join Free